Results 91 to 100 of about 9,997 (164)

Discovery of ferulic acid carbamate derivatives as dual-targeting agents of BuChE and Nrf2 for Alzheimer's disease. [PDF]

J Enzyme Inhib Med Chem
Lao K, Li Y, Xiao Y, Sun Y, Dai Y, Li H, Yang Y, Zhang Y, Wang J, Li W, Gou X, Guan L.   +11 more
europepmc   +1 more source

Deciphering Antidiabetic, Anti-Inflammatory, and Anti-Cholinergic Bioactivities of Withania somnifera (L) Dunal Root Extract: An In Vitro and In Silico Investigation. [PDF]

Chem Biodivers
Mulelu L, Manjia JN, Olofinsan KA, Xulu L, Matsabisa MG.   +4 more
europepmc   +1 more source

BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase. [PDF]

Int J Mol Sci
Jelińska J, Józwiak M, Szeleszczuk Ł, Sikora K, Kamysz W, Kleczkowska P, Gackowski M, Grodner B.   +7 more
europepmc   +1 more source

Trends in First-Time Symptomatic Antidementia Drug Dispensations to Home-Dwelling People in Norway: A Nationwide Register-Based Study. [PDF]

Drugs Real World Outcomes
Øvrebø TG, Sunde AL, Rongve A, Kjosavik SR, Dalen I, Oesterhus R.   +5 more
europepmc   +1 more source

Treatment patterns of symptomatic treatments for Alzheimer's disease and related dementias. [PDF]

BMC Geriatr
Deng H, Lee TA, Gaber CE, Kim K, Crawford SY, Bayliss EA, Singh S, Young JG, Toh S, Li X.   +9 more
europepmc   +1 more source

Bridging the gap: Efficacy of combined therapies for cognitive, behavioral, and functional outcomes in Alzheimer's disease - results from a systematic review and network meta-analysis. [PDF]

J Alzheimers Dis
Boongird C, Anothaisintawee T, Tearneukit W, Wongpipathpong W, Suthutvoravut U, Thongpan M, Pongsettakul N, Attia J, McKay GJ, Rattanasiri S, Thakkinstian A.   +10 more
europepmc   +1 more source

FDA Approval of Donanemab-azbt: A New Dawn in Alzheimer's Disease Treatment. [PDF]

Health Sci Rep
Riaz R, Fatima M, Ramzan S, Rathi D, Fatima F, Farooq M, Shaukat A, Khaliq N, Akilimali A.   +8 more
europepmc   +1 more source

A case report: Neuroimaging in an atypical presentation of Parkinson's disease. [PDF]

S Afr J Psychiatr
Sotobe Mose SNF, Lowton K.
europepmc   +1 more source

A physics-informed graph neural network to approximate docking-based binding affinity for DYRK2 in Alzheimer's drug repurposing. [PDF]

Sci Rep
Gider V, Budak C.
europepmc   +1 more source

Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study. [PDF]

J Manag Care Spec Pharm
Dangpiaei S, Kamal KM, Shoair OA, Al-Mamun MA.   +3 more
europepmc   +1 more source